Company intelligence / Profile preview

Universal Pharmaceutical Industries UNIPHARMA

Ownership: Public · 6621
Development stage: Commercial

Overview

UNIPHARMA manufactures a wide range of pharmaceutical products across multiple therapeutic areas with GMP certification and international collaborations. Annual production capacity up to ~80 million units.

Therapeutic areas: Other
Modalities: Small molecules (tablets, capsules)Creams & ointments (topicals)Syrups & suspensions (liquids)
Industry: Contract Manufacturing Organization

Drug pipeline

7 assets

FOSICARD

Commercial

Indications: Cardiovascular disease

6 more assets in the full pipeline.

Partnerships

Manufactures under license from international pharmaceutical firms.

Beyond the preview

Go deeper on Universal Pharmaceutical Industries UNIPHARMA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Universal Pharmaceutical Industries UNIPHARMA.